Abstract
Sarcoidosis can affect any organ in the body. Frequently extrapulmonary manifestations of the disease are the major cause of morbidity. Treatment of extrapulmonary sarcoidosis often requires consideration of alternative immunosuppressive agents, topical therapy, or therapy that is not specifically directed against the granulomatous inflammation of the disease. This article reviews the clinical presentation and therapy of extrapulmonary sarcoidosis.
MeSH terms
-
Adrenal Cortex Hormones / therapeutic use
-
Bone Diseases / pathology
-
Cardiomyopathies / pathology
-
Eye Diseases / pathology
-
Granuloma* / complications
-
Granuloma* / diagnosis
-
Granuloma* / epidemiology
-
Granuloma* / therapy
-
Humans
-
Immunosuppressive Agents / therapeutic use
-
Joint Diseases / pathology
-
Liver Diseases / pathology
-
Nervous System Diseases / pathology
-
Prevalence
-
Sarcoidosis* / complications
-
Sarcoidosis* / diagnosis
-
Sarcoidosis* / epidemiology
-
Sarcoidosis* / therapy
-
Skin Diseases / pathology
-
Splenic Diseases / pathology
Substances
-
Adrenal Cortex Hormones
-
Immunosuppressive Agents